Poseida Therapeutics (PSTX) Q2 2024 Earnings

May 14Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.53
-0.44
-0.34
-0.25

Details

Expected EPS
-0.42
Actual EPS
-0.25
Surprise EPS
0.17
Surprise Percent
+40.48%

Description

⁨Poseida Therapeutics⁩ (⁦PSTX⁩) has reported earnings of ⁦-0.25⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts